Lactococcus lactis NZ9000
Lactococcus lactis NZ9000 is a well-characterized laboratory strain of L. lactis used as a genetic engineering platform rather than as a conventional probiotic. Research associated with this strain focuses primarily on its use as a vector for expressing foreign proteins, including vaccine antigens, antimicrobial peptides, and immunomodulatory molecules, in in vitro and animal settings. Preclinical models have examined oral delivery of recombinant proteins using this strain. NZ9000 is best understood as a research and bioengineering tool; it is not a recognized commercial probiotic strain with established human efficacy data. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 84 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 20 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+1 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
259 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41437716 →Comparison of Postbiotics and Probiotics of Lactococcus lactis NZ9000 in Alleviating Liver Injury Induced by Bisphenol A via Binding and Removing Bisphenol A in Mouse Model· Molecular Nutrition & Food Research · 2025
-
[2]
PMID 31434565 →Surface display of hirame novirhabdovirus (HIRRV) G protein in Lactococcus lactis and its immune protection in flounder (Paralichthys olivaceus)· Microbial Cell Factories · 2019
-
[3]
Source →Hypoglycemic effect of Lactococcus lactis vaccine containing HSP65-6P277 on streptozotocin-induced type 1 diabetic mice· Zhongguo yaoke daxue xuebao · 2014
-
[4]
PMID 16437622 →Effect of oral Lactococcus lactis containing endostatin on 1, 2-dimethylhydrazine-induced colon tumor in rats· World Journal of Gastroenterology · 2005